GSK plc announced that Dr. Hal Barron was appointed as an Independent Director and Chair of the Nominating and Corporate Governance Committee of Quantinuum Inc. on June 4, 2026. This event was reported on June 9, 2026, and is considered significant from an equity investor perspective.